Picoeukaryote-based biohybrid microrobots for active delivery in the kidney
A biohybrid microrobot is created for active delivery within ultrasmall complex biological environments in the kidney.
Related Articles
USP5 deubiquitylates and stabilizes FcεRIγ to enhance IgE-induced mast cell activation and allergic inflammation
Targeting a modifier of the immunoglobulin E receptor in mast cells inhibits allergic responses in mice.
Beyond Baby KJ: Next Steps in Manufacturing Genome Editing Cures
On this GEN Live, we take a close look at the work behind this successful treatment and perhaps more importantly, we explore how this can…
Giant radar satellite set to probe Earth’s shifts and shudders
NASA and India’s $1.5 billion NISAR mission promises global time lapses of the planet’s ever-changing land and ice
Higher ultra processed food intake linked to increased lung cancer risk
A higher intake of ultra-processed food (UPF) is linked to an increased risk of lung cancer, suggests research published online in the journal Thorax.
What Your Nighttime Breathing Says About Your Health
Once dismissed as just snoring, sleep apnea is now emerging as an early warning sign for serious conditions like Alzheimer’s, heart disease, and depression.
This Tiny Device Could Turn Your Phone Into a Lab-Grade Spectrometer
A tiny, fast, and powerful light analyzer could soon bring lab-grade spectroscopy to your pocket.
Importance of Image Annotation in Machine Learning
Image annotation is the workhorse of AI and ML algorithms, creating a highly accurate ground truth that has a direct influence on algorithmic performance.
Beyond the native repertoire
Design of T cell receptors by artificial intelligence is poised to accelerate cancer immunotherapy
The Em Dash Responds to the AI Allegations
“In recent months, a curious fixation has emerged in corners of academia: the em dash. More specifically, the apparent moral panic around how it is…
Proteomic analyses identify targets, pathways, and cellular consequences of oncogenic KRAS signaling
Proteomic analyses offer insights into how KRAS inhibitors affect oncogenic KRAS signaling.
